- /
- Supported exchanges
- / US
- / STE.NYSE
STERIS plc (STE NYSE) stock market data APIs
STERIS plc Financial Data Overview
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with STERIS plc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get STERIS plc data using free add-ons & libraries
Get STERIS plc Fundamental Data
STERIS plc Fundamental data includes:
- Net Revenue: 5 828 M
- EBITDA: 1 575 M
- Earnings Per Share: 7
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-03
- EPS/Forecast: 2.53
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
STERIS plc News
New
BD Earnings: What To Look For From BDX
Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be reporting results this Monday before the bell. Here’s what to expect. BD met analysts’ revenue expectations last quarte...
Steris PLC (STE) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amid Tariff Challenges
This article first appeared on GuruFocus. Total Revenue Growth: 9% increase as reported. Constant Currency Organic Revenue Growth: 8% increase. Gross Margin: Declined 70 basis points to 43.9%. EBIT M...
STERIS (STE) Q3 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Feb. 5, 2026 at 9 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Daniel A. Carestio Chief Financial Officer — Karen Burton Executive Vice President —...
STE Q3 Earnings Meet, Revenues Beat, Stock Dips in Aftermarket Trading
STERIS plc STE reported third-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.53, up 9% from the year-ago quarter’s figure. The figure matched the Zacks Consensus Estimate. The adjustme...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.